Search research articles
Contact Us
Filters
Showing results (111-120 of 184) with videos related to
Page
of 19
Sort By:
Human Pathology
|
March 17, 2016
Impact of peritumoral and intratumoral budding in esophageal adenocarcinomas
Svenja Thies, Lars Guldener, Julia Slotta-Huspenina, et al.
International Journal of Cancer
|
February 18, 2010
Combined analysis of specific KRAS mutation, BRAF and microsatellite instability identifies prognostic subgroups of sporadic and hereditary colorectal cancer
Inti Zlobec, Michal Kovac, Priska Erzberger, et al.
The Journal of Pathology. Clinical Research
|
August 4, 2017
Cytokeratin-based assessment of tumour budding in colorectal cancer: analysis in stage II patients and prospective diagnostic experience
Viktor H Koelzer, Naziheh Assarzadegan, Heather Dawson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 16, 2004
Prevalence of KIT expression in human tumors
Philip Th Went, Stephan Dirnhofer, Marcel Bundi, et al.
International Journal of Cancer
|
October 27, 2009
High frequency of tumor-infiltrating FOXP3(+) regulatory T cells predicts improved survival in mismatch repair-proficient colorectal cancer patients
Daniel M Frey, Raoul A Droeser, Carsten T Viehl, et al.
Clinical Colorectal Cancer
|
November 4, 2018
Stromal PD-1/PD-L1 Expression Predicts Outcome in Colon Cancer Patients
Jacqueline Wyss, Bastian Dislich, Viktor H Koelzer, et al.
Journal of Pathology Informatics
|
October 21, 2022
Impact of scanner variability on lymph node segmentation in computational pathology
Amjad Khan, Andrew Janowczyk, Felix Müller, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 15, 2010
The loss of the CBX7 gene expression represents an adverse prognostic marker for survival of colon carcinoma patients
Pierlorenzo Pallante, Luigi Terracciano, Vincenza Carafa, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 1, 2016
PTEN alterations of the stromal cells characterise an aggressive subpopulation of pancreatic cancer with enhanced metastatic potential
Martin Wartenberg, Irene Centeno, Stefan Haemmig, et al.
Scientific Reports
|
July 6, 2025
CDX2 loss in colorectal cancer cells is associated with invasive properties and tumor budding
Nils Bodmer, Kristin Uth, Rina Mehmeti, et al.
Page
of 19
Search research articles
Search
Showing results (111-120 of 184) with videos related to
Sort By:
Page
of 19
Human Pathology
|
March 17, 2016
Impact of peritumoral and intratumoral budding in esophageal adenocarcinomas
Svenja Thies, Lars Guldener, Julia Slotta-Huspenina, et al.
International Journal of Cancer
|
February 18, 2010
Combined analysis of specific KRAS mutation, BRAF and microsatellite instability identifies prognostic subgroups of sporadic and hereditary colorectal cancer
Inti Zlobec, Michal Kovac, Priska Erzberger, et al.
The Journal of Pathology. Clinical Research
|
August 4, 2017
Cytokeratin-based assessment of tumour budding in colorectal cancer: analysis in stage II patients and prospective diagnostic experience
Viktor H Koelzer, Naziheh Assarzadegan, Heather Dawson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 16, 2004
Prevalence of KIT expression in human tumors
Philip Th Went, Stephan Dirnhofer, Marcel Bundi, et al.
International Journal of Cancer
|
October 27, 2009
High frequency of tumor-infiltrating FOXP3(+) regulatory T cells predicts improved survival in mismatch repair-proficient colorectal cancer patients
Daniel M Frey, Raoul A Droeser, Carsten T Viehl, et al.
Clinical Colorectal Cancer
|
November 4, 2018
Stromal PD-1/PD-L1 Expression Predicts Outcome in Colon Cancer Patients
Jacqueline Wyss, Bastian Dislich, Viktor H Koelzer, et al.
Journal of Pathology Informatics
|
October 21, 2022
Impact of scanner variability on lymph node segmentation in computational pathology
Amjad Khan, Andrew Janowczyk, Felix Müller, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 15, 2010
The loss of the CBX7 gene expression represents an adverse prognostic marker for survival of colon carcinoma patients
Pierlorenzo Pallante, Luigi Terracciano, Vincenza Carafa, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 1, 2016
PTEN alterations of the stromal cells characterise an aggressive subpopulation of pancreatic cancer with enhanced metastatic potential
Martin Wartenberg, Irene Centeno, Stefan Haemmig, et al.
Scientific Reports
|
July 6, 2025
CDX2 loss in colorectal cancer cells is associated with invasive properties and tumor budding
Nils Bodmer, Kristin Uth, Rina Mehmeti, et al.
Page
of 19